Evidence map›Paper›PMID 42546050›Full record

ArticleBriefings in bioinformatics2026

Mixture diffusion model for multimodal antibody design.

Vasanth Durvasula, Tiara Natasha Binte Sayuti, Jagath C Rajapakse

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vasanth DurvasulaCollege of Computing and Data Science, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore.
Tiara Natasha Binte SayutiCollege of Computing and Data Science, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore.
Jagath C RajapakseCollege of Computing and Data Science, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore.ORCID 0000-0001-7944-1658

Funding

AcRF Tier-2 MOE-T2EP20224-0004
6 · The paper itself

Abstract

Antibody design requires modeling complementarity-determining region (CDR) loops that are highly flexible and adopt diverse conformations to achieve high-affinity antigen binding. Current diffusion-based generative models almost universally adopt unimodal distributions to parameterize sequence-structure transitions, which produce smooth conformations but constrain generation to a single conformational mode. This limitation impedes the exploration of alternative high-affinity binding conformations, particularly for challenging targets where exceptional binders may exist in low-probability regions of the conformational space. To address this, we introduce the mixture diffusion model for multimodal antibody design, a denoising diffusion probabilistic model that uses mixture density parameterizations for both positional and rotational updates. Through experiments on antibody-antigen complexes from the Structural Antibody Database (SAbDab), we find that increasing the number of mixture components improves model performance by capturing distinct canonical-like backbone conformations of CDRs. Our model achieves competitive amino acid recovery and binding-affinity-related metrics while maintaining physically consistent backbones. Through our results, we establish mixture-based diffusion modeling as a practical path toward discovering high-quality antibody conformations that remain inaccessible to conventional single-mode diffusion frameworks.

Indexed as

AntibodiesComplementarity Determining RegionsDiffusionModels, MolecularProtein ConformationAntibodiesComplementarity Determining Regionsantibody designconformational diversitydiffusion modelsGaussian mixturessequence–structure co-design

Identifiers

PMID42546050
PMCPMC13431290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.